Canadian drug makers are facing a $1.1-billion lawsuit for their role in the opioid crisis. A proposed class action filed Wednesday accuses almost two dozen companies of enriching themselves at the expense of vulnerable patients.
Canadian drug makers hit with $1.1B lawsuit for promoting opioids despite risks
Post a Comment